Creagan E - Search Results

1

Ascorbic Acid in Cancer Treatment: Let the Phoenix Fly.

Shenoy N, Creagan E, Witzig T, Levine M. Shenoy N, et al. Among authors: creagan e. Cancer Cell. 2018 Nov 12;34(5):700-706. doi: 10.1016/j.ccell.2018.07.014. Epub 2018 Aug 30. Cancer Cell. 2018. PMID: 30174242 Free PMC article. Review.

2

Complete responses and long-term survivals after systemic chemotherapy for patients with advanced malignant melanoma.

Ahmann DL, Creagan ET, Hahn RG, Edmonson JH, Bisel HF, Schaid DJ. Ahmann DL, et al. Among authors: creagan et. Cancer. 1989 Jan 15;63(2):224-7. doi: 10.1002/1097-0142(19890115)63:2<224::aid-cncr2820630203>3.0.co;2-i. Cancer. 1989. PMID: 2642731 Clinical Trial.

3

Phase I study of recombinant leukocyte A interferon (IFN-alpha 2A, Roferon-A) with doxorubicin in advanced malignant disease.

Creagan ET, Frytak S, Long HJ, Kvols LK. Creagan ET, et al. Cancer. 1989 Sep 1;64(5):1034-7. doi: 10.1002/1097-0142(19890901)64:5<1034::aid-cncr2820640512>3.0.co;2-a. Cancer. 1989. PMID: 2474365

4

Prophylactic cranial irradiation in limited-stage small cell lung cancer.

Liengswangwong V, Bonner JA, Shaw EG, Foote RL, Frytak S, Richardson RL, Creagan ET, Eagan RT, Su JQ. Liengswangwong V, et al. Among authors: creagan et. Cancer. 1995 Mar 15;75(6):1302-9. doi: 10.1002/1097-0142(19950315)75:6<1302::aid-cncr2820750612>3.0.co;2-e. Cancer. 1995. PMID: 7882280

5

Long term results of a phase I/II study of aggressive chemotherapy and sequential upper and lower hemibody radiation for patients with extensive stage small cell lung cancer.

Bonner JA, Eagan RT, Liengswangwong V, Frytak S, Shaw EG, Evans RG, Creagan ET, Richardson RL. Bonner JA, et al. Among authors: creagan et. Cancer. 1995 Aug 1;76(3):406-12. doi: 10.1002/1097-0142(19950801)76:3<406::aid-cncr2820760310>3.0.co;2-s. Cancer. 1995. PMID: 8625121 Clinical Trial.

6

A phase I-II trial of the combination of recombinant leukocyte A interferon and recombinant human interferon-gamma in patients with metastatic malignant melanoma.

Creagan ET, Loprinzi CL, Ahmann DL, Schaid DJ. Creagan ET, et al. Cancer. 1988 Dec 15;62(12):2472-4. doi: 10.1002/1097-0142(19881215)62:12<2472::aid-cncr2820621203>3.0.co;2-g. Cancer. 1988. PMID: 3142675

7

Cisplatin-based chemotherapy for neoplasms arising from salivary glands and contiguous structures in the head and neck.

Creagan ET, Woods JE, Rubin J, Schaid DJ. Creagan ET, et al. Cancer. 1988 Dec 1;62(11):2313-9. doi: 10.1002/1097-0142(19881201)62:11<2313::aid-cncr2820621110>3.0.co;2-4. Cancer. 1988. PMID: 3179947

8

The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study.

Bonner JA, McGinnis WL, Stella PJ, Marschke RF Jr, Sloan JA, Shaw EG, Mailliard JA, Creagan ET, Ahuja RK, Johnson PA. Bonner JA, et al. Among authors: creagan et. Cancer. 1998 Mar 15;82(6):1037-48. Cancer. 1998. PMID: 9506347 Clinical Trial.

9

Recombinant leukocyte A interferon with doxorubicin. A phase I study in advanced solid neoplasms and implications for hepatocellular carcinoma.

Creagan ET, Long HJ, Frytak S, Moertel CG. Creagan ET, et al. Cancer. 1988 Jan 1;61(1):19-22. doi: 10.1002/1097-0142(19880101)61:1<19::aid-cncr2820610105>3.0.co;2-8. Cancer. 1988. PMID: 2825959

10

An evaluation of recombinant leukocyte A interferon with aspirin in patients with metastatic renal cell cancer.

Creagan ET, Buckner JC, Hahn RG, Richardson RR, Schaid DJ, Kovach JS. Creagan ET, et al. Cancer. 1988 May 1;61(9):1787-91. doi: 10.1002/1097-0142(19880501)61:9<1787::aid-cncr2820610911>3.0.co;2-q. Cancer. 1988. PMID: 3162699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

192 results

Search Page